Drag a card by its title · ⚙ to size, swap or remove

The company

Monte Rosa Therapeutics, Inc.

GLUE · Nasdaq

Health CareBiotechnologyNot moving yet

GLUE stood above a rising 150-day average in 39 of the last 52 weekly readings, and has been out of that trend for the last 12 weeks. It is 43.4% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 12
Industry in uptrend: 15% -17 in 4 wk
Insider buys, 12 months: $0
Insider sales, 12 months: $8.2M
Officials’ trades on record: 0
Institutions holding: 186 (+3)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 39 of 52 weeks.

17 Apr – 16 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0

Sale orders, 12 months33

Buyers · sellers0 · 8

Who	Did	Shares	Traded
Matthew BowenPrincipal Accounting Officer	sold	13at $10.56	5 Oct 2026filed 6 Oct 2026
Markus WarmuthPresident & CEO	sold	9,500at $23.18	16 Jul 2026filed 17 Jul 2026
Jennifer ChampouxChief Operating Officer	sold	4,351at $23.38	15 Jul 2026filed 16 Jul 2026
Sharon TownsonChief Scientific Officer	sold	5,600at $23.25	6 Jul 2026filed 7 Jul 2026
Sharon TownsonChief Scientific Officer	sold	400at $24.13	6 Jul 2026filed 7 Jul 2026
Filip JankuChief Medical Officer	sold	5,407at $24.50	30 Jun 2026filed 1 Jul 2026
Anthony M. ManningDirector	sold	10,000at $23.11	29 Jun 2026filed 30 Jun 2026
Filip JankuChief Medical Officer	sold	6,000at $22.95	29 Jun 2026filed 30 Jun 2026
Filip JankuChief Medical Officer	sold	30,000at $21.42	24 Jun 2026filed 25 Jun 2026
Jennifer ChampouxChief Operating Officer	sold	2,175at $20.00	23 Jun 2026filed 25 Jun 2026
Sharon TownsonChief Scientific Officer	sold	3,000at $20.00	23 Jun 2026filed 25 Jun 2026
Filip JankuChief Medical Officer	sold	11,845at $20.22	23 Jun 2026filed 25 Jun 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders186+3 on the quarter

New · exited29 · 25

Reported value$2.0B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
NEA Management Company, LLCunchanged · filed 14 Aug 2026	7,692,298$186.2M	00.0%
BlackRock, Inc.added · filed 7 Aug 2026	6,843,087$165.6M	+1,205,403+21.4%
TCG Crossover Management, LLCunchanged · filed 14 Aug 2026	4,622,151$111.9M	00.0%
Vestal Point Capital, LPadded · filed 14 Aug 2026	4,600,000$111.3M	+996,535+27.7%
BVF INCunchanged · filed 14 Aug 2026	4,460,886$108.0M	00.0%
BAKER BROS. ADVISORS LPunchanged · filed 14 Aug 2026	4,345,736$105.2M	00.0%
STATE STREET CORPadded · filed 7 Aug 2026	3,731,416$90.3M	+377,436+11.3%
MONTANOVA CAPITAL, LLCreduced · filed 14 Aug 2026	3,549,539$85.9M	-677,270−16.0%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	3,412,927$82.6M	+312,682+10.1%
Versant Venture Management, LLCunchanged · filed 12 Aug 2026	3,180,780$77.0M	00.0%